Delivery Order SPE2DB24D2003-SPE2DB25FXMU2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $2,915.55. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $28,993.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $13,660.97 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,658.42 to supply Descovy 200-25 mg tablets in quantities of 30, with performance in Conshohocken, Pennsylvania. The award, issued on August 18, 2025, represents a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $21,125.75 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. As a child order under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency awarded a delivery order valued at $16,346.38 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's proven...
- The Defense Logistics Agency awarded a delivery order valued at $48,221.18 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,812.16 and an ultimate completion date of April 22, 2025. The contract was competitively awarded with no set-aside designation. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the critical pharmaceutical support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,728.46 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMU2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,825.06 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed on September 16, 2025, with an ultimate completion date of September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger indefinite delivery contract vehicle—the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and running through December 2026—which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has consistently demonstrated its capability to compete for and execute federal medical supply contracts through open competition, with a diverse portfolio spanning brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Descovy, an antiretroviral medication, represents a routine pharmaceutical procurement supporting military healthcare operations through the established DLA Troop Support Medical contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.8k | 9/16/25 |